Endocrinol Metab.  2013 Mar;28(1):17-19. 10.3803/EnM.2013.28.1.17.

Serum Albumin Levels: A Simple Answer to a Complex Problem? Are We on the Right Track of Assessing Metabolic Syndrome?

• Kim S
• Kang S

• KMID: 1805940
• DOI: http://doi.org/10.3803/EnM.2013.28.1.17

Abstract

No abstract available.

MeSH Terms

Serum Albumin
Track and Field
Serum Albumin

Reference

1. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005. 115:1111–1119.

2. Bae JC, Seo SH, Hur KY, Kim JH, Lee MS, Lee MK, Lee WY, Rhee EJ, Oh KW. Association between serum albumin, insulin resistance, and incident diabetes in nondiabetic subjects. Endocrinol Metab. 2013. 28:26–32.

3. Cho HM, Kim HC, Lee JM, Oh SM, Choi DP, Suh I. The association between serum albumin levels and metabolic syndrome in a rural population of Korea. J Prev Med Public Health. 2012. 45:98–104.

4. Peavy DE, Taylor JM, Jefferson LS. Time course of changes in albumin synthesis and mRNA in diabetic and insulin-treated diabetic rats. Am J Physiol. 1985. 248(6 Pt 1):E656–E663.

5. Ishizaka N, Ishizaka Y, Nagai R, Toda E, Hashimoto H, Yamakado M. Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. Atherosclerosis. 2007. 193:373–379.

6. Kadono M, Hasegawa G, Shigeta M, Nakazawa A, Ueda M, Yamazaki M, Fukui M, Nakamura N. Serum albumin levels predict vascular dysfunction with paradoxical pathogenesis in healthy individuals. Atherosclerosis. 2010. 209:266–270.

7. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004. 24:816–823.

8. Turell L, Carballal S, Botti H, Radi R, Alvarez B. Oxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment. Braz J Med Biol Res. 2009. 42:305–311.

9. Candiano G, Petretto A, Bruschi M, Santucci L, Dimuccio V, Prunotto M, Gusmano R, Urbani A, Ghiggeri GM. The oxido-redox potential of albumin methodological approach and relevance to human diseases. J Proteomics. 2009. 73:188–195.

10. Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002. 106:2919–2924.

11. Hostmark AT, Tomten SE, Berg JE. Serum albumin and blood pressure: a population-based, cross-sectional study. J Hypertens. 2005. 23:725–730.

12. Djousse L, Rothman KJ, Cupples LA, Arnett DK, Ellison RC. NHLBI Family Heart Study. Relation between serum albumin and carotid atherosclerosis: the NHLBI Family Heart Study. Stroke. 2003. 34:53–57.

13. Van Campenhout A, Van Campenhout C, Lagrou AR, Moorkens G, De Block C, Manuel-y-Keenoy B. Iron-binding antioxidant capacity is impaired in diabetes mellitus. Free Radic Biol Med. 2006. 40:1749–1755.

14. Lim PS, Cheng YM, Yang SM. Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology (Carlton). 2007. 12:18–24.

15. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989. 2:1434–1436.